# Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability

> **NCT03857997** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 62 (actual)

## Conditions studied

- Patients With Intellectual Disabilities Without an Obvious Clinical Diagnosis
- Patients With Normal Array CGH and Previous Negative Genetic Investigations (WES-solo or WES-trio)

## Interventions

- **BIOLOGICAL:** Patient blood sampling
- **BIOLOGICAL:** Parents blood sampling

## Key facts

- **NCT ID:** NCT03857997
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-04
- **Primary completion:** 2019-12-27
- **Final completion:** 2021-02-02
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2021-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857997, "Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03857997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*